Loading Events

« All Events

  • This event has passed.

Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic

September 17 @ 2:00 pm - 3:00 pm EDT

Influenza surveillance data reported to the World Health Organization’s FluNet platform from three Southern Hemisphere countries (Australia, Chile, and South Africa) indicated low influenza activity during June through August 2020, months that comprise the typical Southern Hemisphere influenza season. The low influenza activity observed in the Southern Hemisphere might reflect the impact of non-pharmaceutical interventions implemented to reduce the spread of SARS-CoV-2, the virus that causes COVID-19. However, it is not possible to predict influenza activity or the severity of the upcoming influenza season in the United States with the potential for co-circulation of influenza viruses and SARS-CoV-2. While vaccination remains the best way to prevent influenza, antiviral medications are an essential adjunct to vaccination—especially for treating outpatients with suspected or confirmed influenza, in persons at high risk for influenza complications, in those with progressive disease, and hospitalized influenza patients.
During this COCA call, clinicians will hear an overview of CDC’s recommendations for health care providers regarding influenza diagnostics and the use of antiviral medications for the 2020-2021 influenza season, including considerations during the ongoing COVID-19 pandemic.
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.
Activity-specific Objectives
At the conclusion of the session, the participant will be able to accomplish the following—

  1. Review influenza activity since the onset of the COVID-19 pandemic.
  2. Provide background on influenza tests and antivirals for influenza.
  3. Describe influenza testing guidance for patients with acute respiratory illness for the 2020-2021 season, including during community co-circulation of influenza viruses and SARS-CoV-2.
  4. Describe antiviral treatment recommendations for patients with suspected or confirmed influenza for the 2020-2021 season, including during community co-circulation of influenza viruses and SARS-CoV-2.

A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/1604984692
Or iPhone one-tap:
US: +16692545252,,1604984692# or +16468287666,,1604984692#
Or Telephone: Dial(for higher quality, dial a number based on your current location): US: +1 669 254 5252 or +1 646 828 7666
Webinar ID: 160 498 4692
A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/1604984692
Or iPhone one-tap:
US: +16692545252,,1604984692# or +16468287666,,1604984692#
Or Telephone: Dial(for higher quality, dial a number based on your current location): US: +1 669 254 5252 or +1 646 828 7666
Webinar ID: 160 498 4692

Details

Date:
September 17
Time:
2:00 pm - 3:00 pm EDT

Venue

CDC Clinician Outreach and Communication Activity

Organizer

CDC Clinician Outreach and Communication Activity
Phone:
1.669.254.5252 or 1.646.828.7666 Access code 160 498 4692